The Clorox Company $CLX Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund

Key Points

• Fjarde AP Fonden Fourth Swedish National Pension Fund has reduced its stake in The Clorox Company by 55.2%, now holding 9,829 shares valued at approximately $1.447 million.
• Clorox's stock recently increased by 0.5% and has a market capitalization of $14.94 billion, with a PE ratio of 18.74.
• The company announced an increase in its quarterly dividend to $1.24, reflecting a 4.1% dividend yield and an annualized dividend of $4.96.

Fjarde AP Fonden Fourth Swedish National Pension Fund decreased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 55.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,829 shares of the company's stock after selling 12,102 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Clorox were worth $1,447,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Rockefeller Capital Management L.P. boosted its position in Clorox by 5.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 16,003 shares of the company's stock valued at $2,599,000 after acquiring an additional 847 shares in the last quarter. CreativeOne Wealth LLC boosted its position in Clorox by 78.3% during the 4th quarter. CreativeOne Wealth LLC now owns 2,332 shares of the company's stock valued at $379,000 after acquiring an additional 1,024 shares in the last quarter. United Capital Financial Advisors LLC boosted its position in Clorox by 20.7% during the 4th quarter. United Capital Financial Advisors LLC now owns 3,449 shares of the company's stock valued at $560,000 after acquiring an additional 591 shares in the last quarter. NewEdge Advisors LLC boosted its position in Clorox by 1.0% during the 4th quarter. NewEdge Advisors LLC now owns 13,447 shares of the company's stock valued at $2,184,000 after acquiring an additional 131 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co boosted its position in Clorox by 6.2% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 155,886 shares of the company's stock valued at $25,317,000 after acquiring an additional 9,141 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Shares of Clorox stock traded up $0.5720 on Friday, hitting $120.4120. The company's stock had a trading volume of 710,127 shares, compared to its average volume of 1,635,806. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 1 year low of $117.35 and a 1 year high of $171.37. The firm has a fifty day moving average price of $124.31 and a 200-day moving average price of $135.57. The company has a market capitalization of $14.73 billion, a price-to-earnings ratio of 18.47, a price-to-earnings-growth ratio of 0.97 and a beta of 0.49.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period in the previous year, the business earned $1.82 EPS. Clorox's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. Clorox's dividend payout ratio is 76.07%.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent research reports. Evercore ISI set a $140.00 target price on Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Morgan Stanley lowered their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Barclays lowered their price objective on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Wells Fargo & Company raised their price objective on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. Finally, Jefferies Financial Group lowered their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average price target of $143.36.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.